Fukuoka, Japan

Hiroaki Mizuta


Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 169(Granted Patents)


Location History:

  • Chikujo-gun, JP (1998)
  • Fukuoka, JP (1997 - 1999)

Company Filing History:


Years Active: 1997-1999

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Hiroaki Mizuta: Innovator in Pharmaceutical Preparations

Introduction

Hiroaki Mizuta is a notable inventor based in Fukuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. With a total of 3 patents, Mizuta's work focuses on enhancing the efficacy and safety of medications.

Latest Patents

Mizuta's latest patents include a "Sustained release microsphere preparation containing antipsychotic drug." This invention involves a sustained release microsphere preparation produced by incorporating a hydrophobic antipsychotic drug, such as bromperidol or haloperidol, into a base made of high molecular weight polymers like polylactic acid or poly(lactic-co-glycolic) acid. This innovative approach aims to improve the therapeutic outcomes for patients requiring antipsychotic treatment. Another significant patent is related to liposome preparation, which further showcases his expertise in drug formulation.

Career Highlights

Hiroaki Mizuta is currently associated with Yoshitomi Pharmaceutical Industries, Ltd., where he continues to advance his research and development efforts. His work has been instrumental in creating formulations that enhance drug delivery and patient compliance.

Collaborations

Mizuta collaborates with esteemed colleagues such as Shigemi Kino and Tomonori Osajima. Their combined expertise contributes to the innovative projects at Yoshitomi Pharmaceutical Industries, Ltd.

Conclusion

Hiroaki Mizuta's contributions to pharmaceutical innovations highlight his commitment to improving drug delivery systems. His patents reflect a deep understanding of the complexities involved in medication formulation, ultimately benefiting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…